The Prevalence and Economic Impact of Low-Enrolling Clinical Studies at an Academic Medical Center

  title={The Prevalence and Economic Impact of Low-Enrolling Clinical Studies at an Academic Medical Center},
  author={Darlene Kitterman and Steven Kunyuan Cheng and David M. Dilts and Eric S. Orwoll},
  journal={Academic Medicine},
Purpose The authors assessed the prevalence and associated economic impact of low-enrolling clinical studies at a single academic medical center. Method The authors examined all clinical studies receiving institutional review board (IRB) review between FY2006 and FY2009 at Oregon Health & Science University (OHSU) for recruitment performance and analyzed them by type of IRB review (full-board, exempt, expedited), funding mechanism, and academic unit. A low-enrolling study included those with… 

Commentary: Improving participant recruitment in clinical and translational research.

Four areas are described in which academic health centers (AHCs) could invest more effort and resources to improve the recruitment of research participants, including terminating studies that are underenrolling early.

Characteristics and Causes for Non-Accrued Clinical Research (NACR) at an Academic Medical Institution

Results suggest some simple strategies that investigators and institutions may use to reduce NACR, including careful feasibility assessment, reduction of institutional delays, and prompt initiation of subject accrual for multi-center studies using competitive enrollment.

Factors Associated with Clinical Research Recruitment in a Pediatric Academic Medical Center—A Web-Based Survey

Recruiting in person may promote reaching an acceptable target enrollment in pediatric as well as adult clinical research and future research is needed on larger and more diverse samples.

Factors Associated With the Acceleration of Patient Enrollment in Clinical Studies: A Cross-Sectional Study

Hospitals in rural areas were more effective in promoting patient enrollment than those in urban areas and site visits and CRC participation in data input to electronic data capture had a significant effect on patient enrollment promotion.

Cost analysis and efficacy of recruitment strategies used in a large pragmatic community-based clinical trial targeting low-income seniors: a comparative descriptive analysis

The ”health care providers” strategies were especially successful — at a moderate cost per enrolled, while the "media" strategies were less effective, short lasting, and more costly.

Ohio CTSAs Implement a Reliant IRB Model for Investigator‐Initiated Multicenter Clinical Trials

The three Ohio CTSA sites have collaborated to create a novel IRB review concept with the hopes of addressing this concern and achieving a more effective and efficientIRB review of multicentered clinical research studies.

Terminated Trials in the Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination

Further research is needed to identify best practices for disseminating the experience and data resulting from terminated trials in order to help ensure maximal societal benefit from the investments of trial participants and others involved with the study.

Screening intervention to identify eligible patients and improve accrual to phase II-IV oncology clinical trials.

Man manually screening patient records increased enrolment to specific clinical trials and a screening intervention process, involving a dedicated screening coordinator, should be considered to improve clinical trial accrual.

Accrual and Recruitment Practices at Clinical and Translational Science Award (CTSA) Institutions: A Call for Expectations, Expertise, and Evaluation

Many CTSAs lack the necessary frame work to support study accrual, and recommend developing interdepartmental coordination and integrated informatics infrastructure to drive the conduct, evaluation, and improvement of recruitment practices.

A review of the impact of utilising electronic medical records for clinical research recruitment

Using electronic medical records for recruitment was found to be effective due to its capability for patient identification outside working hours and fast processing time, which was particularly useful for clinical trials in acute conditions.



A Sense of Urgency: Evaluating the Link between Clinical Trial Development Time and the Accrual Performance of Cancer Therapy Evaluation Program (NCI-CTEP) Sponsored Studies

A large percentage of oncology clinical trials do not achieve minimum projected accruals, and trial development time appears to be one important predictor of the likelihood of successfully achieving the minimum accrual goals.

Clinical trial metrics: Protocol performance and resource utilization from 14 cancer centers.

  • H. DurivageK. D. Bridges
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2009
Effective rules governing selection of IND and CG TCTs for activation are needed to enable centers to re-direct valuable resources to useful activities without adverse effect on overall enrollment.

Predicting Accrual Achievement: Monitoring Accrual Milestones of NCI-CTEP–Sponsored Clinical Trials

The time to first patient enrollment and expected time to accrual goal are shown to be valid measures to evaluate the likelihood of achieving the minimum projected accruals by study closure.

Applying results of randomised trials to clinical practice: impact of losses before randomisation.

The problem of generalisability in randomised clinical trials was highlighted by studies that entered only 10-14% of screened patients. To determine the magnitude and source of prerandomisation

Phase III Clinical Trial Development: A Process of Chutes and Ladders

The length, variability, and low accrual results demonstrate the need for the NCI clinical trials system to be reengineered, and the first comprehensive review of all the time and steps required to open a phase III oncology clinical trial is completed.

Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials

A pilot study to determine the extent of trial closure due to poor accrual, feasibility of identifying trial factors associated with sufficient accruality, impact of redesign strategies on trial accruAL, and accruals designating high failure risk in the clinical trials cooperative group (CTCG) setting.

Obstacles facing translational research in academic medical centers

Translational research is hindered by insufficient targeted resources, a shortage of qualified investigators, an academic culture that hinders collaboration between clinical and laboratory‐based investigators, a traditional structure of the AMC that favors departmental efforts over interdisciplinary programs, an increasing regulatory burden, and a lack of specific mechanisms within the AMC for facilitating solutions to these problems.

Linking Scientific Discovery and Better Health for the Nation: The First Three Years of the NIH's Clinical and Translational Science Awards

  • R. CaliffL. Berglund
  • Medicine
    Academic medicine : journal of the Association of American Medical Colleges
  • 2010
The authors describe the challenges encountered during the CTSA and discuss the promise of this vital national health care initiative, which is essential to creating a pipeline for the scientific workforce needed to conduct research that will, in turn, provide a rational evidence base for better health in the United States.

Reengineering the National Clinical and Translational Research Enterprise: The Strategic Plan of the National Clinical and Translational Science Awards Consortium

The authors report in detail on the planning process that was used to engage stakeholders and to identify, refine, and ultimately implement the CTSA program's overarching strategic goals, and the implications and likely impact of this strategic planning process as it is applied among the nation's academic health centers.